Nifuroxazide
From Wikipedia, the free encyclopedia
 |
|
|
Nifuroxazide
|
|
| Systematic (IUPAC) name | |
| 4-Hydroxybenzoic acid [(5-nitro-2-furanyl)methylene]hydrazide | |
| Identifiers | |
| CAS number | |
| ATC code | A07 |
| PubChem | |
| Chemical data | |
| Formula | C12H9N3O5 |
| Mol. mass | 275.2 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Nifuroxazide (INN) is an oral nitrofuran antibiotic used to treat colitis and diarrhea. It is sold under the brand names Ambatrol, Antinal, Bacifurane, Nifrozid, Ercefuryl, Endiex (CZ, SK, PL) and Septidiaryl. It is sold in capsule form and also as a suspension.
Maurice Claude Ernest Carron patented the drug in the United States in 1966 [1]. Subsequent patents issued to Germano Cagliero of Marxer S.p.A describe the use of nifuroxazide as an antibiotic used to treat livestock.[2]
[edit] Notes
- ^ USPTO No. 3290213 |http://www.google.com/patents?id=f2dwAAAAEBAJ
- ^ USPTO No 4093746 |http://www.google.com/patents?vid=USPAT4093746
|
||||||||||||||||||||
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
